Efficacy assessments of SF001, a next-generation polyene antifungal, in a neutropenic mouse model of invasive fusariosis

By sjmartinez • April 2, 2025

Gebremariam T, Gu Y, Patterson H, Youssef E, Alkhazraji S, Elsayed T, Wiederhold NP, Ibrahim AS. Efficacy assessments of SF001, a next-generation polyene antifungal, in a neutropenic mouse model of invasive fusariosis. Antimicrob Agents Chemother. 2025 Apr 1:e0180224. doi: 10.1128/aac.01802-24. Epub ahead of print. PMID: 40167370.

Tags: antifungal agents, Fusarium, Harbor UCLA, infection model, Infectious Diseases, liposomal amphotericin B, mouse, Publications, SF001

CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy

Marshalek JP, Qing X, Tomassetti S. CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy. World J Oncol. 2025[...]

Racial differences in atherosclerosis and coronary plaque characteristics using enhanced AI quantification (RACE-AI)

Iskander B, Punnanithinont N, Kambalapalli S, Ichikawa K, Kinninger A, Krishnan S, Lakshmanan S, Roy S, Budoff M. Racial differences in atherosclerosis and coronary plaque[...]

Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial

Giganti MJ, Chew KW, Moser C, Eron JJ, Pinilla M, Li JZ, Ritz J, Javan AC, Wohl DA, Daar ES, Currier JS, Smith DM, Hughes[...]